These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31582661)

  • 1. Potentiation of Glucagon-Like Peptide-2 Dynamics by Methotrexate Administration in Rat Small Intestine.
    Machida M; Shiga S; Machida T; Ohno M; Iizuka K; Hirafuji M
    Biol Pharm Bull; 2019; 42(10):1733-1740. PubMed ID: 31582661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.
    Kissow H; Viby NE; Hartmann B; Holst JJ; Timm M; Thim L; Poulsen SS
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):39-48. PubMed ID: 22729158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
    Sun D; Liu L; Mao S; Zhu W; Liu J
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.
    Nelson DW; Murali SG; Liu X; Koopmann MC; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1175-84. PubMed ID: 18256135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration.
    Hirotani Y; Yamamoto K; Ikeda K; Arakawa Y; Li J; Kitamura K; Kurokawa N; Tanaka K
    Biol Pharm Bull; 2006 Nov; 29(11):2327-30. PubMed ID: 17077541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.
    Kissow H; Hartmann B; Holst JJ; Poulsen SS
    Gut; 2013 Dec; 62(12):1724-33. PubMed ID: 23086829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of glucagon-like peptide 2 pathway member expression in bovine gastrointestinal tract.
    Connor EE; Baldwin RL; Capuco AV; Evock-Clover CM; Ellis SE; Sciabica KS
    J Dairy Sci; 2010 Nov; 93(11):5167-78. PubMed ID: 20965332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.
    Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Saeki T; Tanaka I
    Eur J Pharmacol; 2004 Mar; 488(1-3):213-8. PubMed ID: 15044053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
    Dubé PE; Forse CL; Bahrami J; Brubaker PL
    Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1554-62. PubMed ID: 19776251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
    Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
    Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
    Hytting-Andreasen R; Balk-Møller E; Hartmann B; Pedersen J; Windeløv JA; Holst JJ; Kissow H
    PLoS One; 2018; 13(6):e0198046. PubMed ID: 29864142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mRNA for proglucagon and glucagon-like peptide-2 (GLP-2) receptor in the ruminant gastrointestinal tract and the influence of energy intake.
    Taylor-Edwards CC; Burrin DG; Matthews JC; McLeod KR; Holst JJ; Harmon DL
    Domest Anim Endocrinol; 2010 Oct; 39(3):181-93. PubMed ID: 20688461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV.
    Drucker DJ; Shi Q; Crivici A; Sumner-Smith M; Tavares W; Hill M; DeForest L; Cooper S; Brubaker PL
    Nat Biotechnol; 1997 Jul; 15(7):673-7. PubMed ID: 9219272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2.
    Brubaker PL; Izzo A; Hill M; Drucker DJ
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E1050-8. PubMed ID: 9227451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
    Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
    J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.